已收盤 05-08 16:00:00 美东时间
+0.047
+0.17%
Transamerica launches two active ETFs offering large-cap value and bond exposure with low fees, experienced subadvisors and long-term portfolio focus.
2025-12-23 03:03
June 15 (Reuters) - Johnson & Johnson JNJ.N: INVESTIGATIONAL COMBINATION OF FIRST-IN-CLASS BISPECIFICS TALVEY® AND TECVAYLI® SHOWS DEEP AND DURABLE RESPONSES IN HEAVILY PRETREATED MULTIPLE MYELOMA PAT...
2025-06-15 15:21
Johnson & Johnson announced new results from the Phase 2 RedirecTT-1 study, evaluating the investigational combination of TALVEY® (talquetamab-tgvs) and TECVAYLI® (teclistamab-cqyv) for treating heavi...
2025-06-15 15:15